Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Moderna’s Omicron BA.1 booster shows superior antibody response over Spikevax

Data indicates that the superior response is sustained for at least three months

- PMLiVE

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

Patients with chronic ITP may live with an increased risk of severe bleeding events

- PMLiVE

Incyte’s Opzelura shows significant improvements in phase 3 vitiligo trial

The positive data has been published in The New England Journal of Medicine

Medscape Education: Key Takeaways from Tapas and Trends

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

Medscape Education

Medscape Education #ESC Tapas and Trends Full Panel Discussion

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

Medscape Education

- PMLiVE

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

Bedrock Healthcare Communications

- PMLiVE

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

Origins – The Patient Focused Specialists

- PMLiVE

Global leaders pledge $2.6bn at World Health Summit in efforts to end polio

The pledging moment was a milestone in fulfilling the $4.8bn required to implement the GPEI Strategy

- PMLiVE

Merck and Bill & Melinda Gates Institute sign licensing agreement for tuberculosis candidates

The non-profit will determine their potential for inclusion in new affordable treatment regimens

- PMLiVE

FDA awards over $38m for advancement of rare disease treatments

Grants will support clinical trials, natural history studies and regulatory science tools

- PMLiVE

New study identifies gene associated with strong immune response to COVID-19 vaccines

Two out of every five people in the UK carry a version of an HLA gene called HLA-DQB1*06

- PMLiVE

Kite’s CAR-T therapy Yescarta granted EC approval in second-line lymphoma

The decision is based on results from the phase 2 ZUMA-7 study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links